Sonoma Pharmaceuticals Stock Price on June 21, 2024
| SNOA Stock | USD 2.73 0.05 1.87% |
Below is the normalized historical share price chart for Sonoma Pharmaceuticals extending back to January 25, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sonoma Pharmaceuticals stands at 2.73, as last reported on the 24th of December, with the highest price reaching 2.73 and the lowest price hitting 2.68 during the day.
If you're considering investing in Sonoma Stock, it is important to understand the factors that can impact its price. Sonoma Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0333, which indicates the firm had a -0.0333% return per unit of risk over the last 3 months. Sonoma Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sonoma Pharmaceuticals' Variance of 25.79, coefficient of variation of (1,931), and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide.
At present, Sonoma Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 15.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 262.8 K. . At present, Sonoma Pharmaceuticals' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.24, whereas Price To Sales Ratio is forecasted to decline to 0.10. Sonoma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of January 2007 | 200 Day MA 3.7901 | 50 Day MA 2.8194 | Beta 1.378 |
Sonoma |
Sharpe Ratio = -0.0333
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNOA |
Estimated Market Risk
| 5.06 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sonoma Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sonoma Pharmaceuticals by adding Sonoma Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6681 | Enterprise Value Ebitda (0.17) | Price Sales 0.2773 | Shares Float 942.5 K | Wall Street Target Price 19.5 |
Related Headline
Universe Pharmaceuticals Headline on 21st of June 2024
Acquisition by White John V of 10050 shares of Universe Phar... by White John V
Filed transaction by Universe Pharmaceuticals Officer Ceo,union Planters Bank, Memph. Grant, award or other acquisition pursuant to Rule 16b-3
Sonoma Pharmaceuticals Valuation on June 21, 2024
It is possible to determine the worth of Sonoma Pharmaceuticals on a given historical date. On June 21, 2024 Sonoma was worth 3.78 at the beginning of the trading date compared to the closed value of 4.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sonoma Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Sonoma Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sonoma Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sonoma Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.50 | 4.20 | 3.30 | 4.08 | 492,408 | |
06/21/2024 | 3.78 | 4.36 | 3.69 | 4.03 | 179,080 |
| 3.95 | 4.03 | 3.72 | 3.80 | 77,923 |
| Backtest Sonoma Pharmaceuticals | | | Sonoma Pharmaceuticals History | | | Sonoma Pharmaceuticals Valuation | Previous | Next |
Sonoma Pharmaceuticals Trading Date Momentum on June 21, 2024
| On June 24 2024 Sonoma Pharmaceuticals was traded for 3.80 at the closing time. The top price for the day was 4.03 and the lowest listed price was 3.72 . The trading volume for the day was 77.9 K. The trading history from June 24, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 5.71% . The trading price change against the current closing price is 4.22% . |
Sonoma Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Sonoma Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sonoma Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sonoma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sonoma Pharmaceuticals Stock history
Sonoma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sonoma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sonoma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sonoma Pharmaceuticals stock prices may prove useful in developing a viable investing in Sonoma Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 454.5 K | 262.8 K | |
| Net Loss | -4.6 M | -4.9 M |
Sonoma Pharmaceuticals Quarterly Net Working Capital |
|
Sonoma Pharmaceuticals Stock Technical Analysis
Sonoma Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sonoma Pharmaceuticals Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Sonoma Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sonoma Pharmaceuticals December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Sonoma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonoma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Sonoma Pharmaceuticals stock market strength indicators, traders can identify Sonoma Pharmaceuticals entry and exit signals to maximize returns
Sonoma Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sonoma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Sonoma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sonoma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sonoma Stock analysis
When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |